Skip to content
Seqlense EUR-Lex

Commission Decision of 02/02/2004 declaring a concentration to be compatible with the common market (Case No COMP/M.3350 - NORSK HYDRO / WINGAS / HYDROWINGAS JV) according to Council Regulation (EEC) No 4064/89 (Only the English text is authentic)

CELEX
32004M3350
Document type
DEC_ENTSCHEID
Sector
Legislation
Date of document
2004-02-02
In force since
2004-02-02
Status
In force

Text

This document has no article-level structure in its source. Full text below.

Final report of the Hearing Officer in case COMP/37.978 — Methylglucamine (pursuant to Article 15 of Commission Decision 2001/462/EC, ECSC of 23 May 2001 on the terms of reference of Hearing Officers in certain competition proceedings (OJ L 162, 19.6.2001, p. 21)) (Text with EEA relevance) Official Journal C 036 , 10/02/2004 P. 0007 - 0007 Final report of the Hearing Officer in case COMP/37.978 - Methylglucamine (pursuant to Article 15 of Commission Decision 2001/462/EC, ECSC of 23 May 2001 on the terms of reference of Hearing Officers in certain competition proceedings (OJ L 162, 19.6.2001, p.

21)) (2004/C 36/07) (Text with EEA relevance) During the oral and written procedures, no real problem concerning the right to be heard was raised by the parties. In view of the written replies to the statement of objections and the results of the hearing, the Directorate-General for Competition has decided to consider the infringement to have ceased on 31 December 1999 as clear evidence of it existed only up to that date, whereas the statement of objections referred to September 2000. Account is taken of this in the calculation of the fine. The draft final decision does not contain any objections on which the firms did not have to comment.

Done at Brussels, 19 November 2002. Serge Durande

Relations

What this act cites, and what cites it.

Show relations

Versions

Point-in-time consolidated versions of this act.

Show versions